Pilot study: inflammation and coronary artery disease. Role of AT1 [angiotensin II type I] receptor antagonism
Phase of Trial: Phase IV
Latest Information Update: 03 Dec 2008
At a glance
- Drugs Telmisartan (Primary)
- Indications Coronary artery disease; Essential hypertension
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 31 Aug 2018 Biomarkers information updated
- 03 Dec 2008 Last checked against ClinicalTrials.gov record.
- 28 Mar 2007 New trial record.